Search
Lymphoma Clinical Trials in Richardson, TX
A listing of 1 Lymphoma clinical trials in Richardson, TX actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
1 - 1 of 1
The city of Richardson, Texas, currently has 1 active clinical trials seeking participants for Lymphoma research studies.
Featured Trial
Paid Clinical Studies Nationwide
Recruiting
Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.
Featured Trial
Cannabis Research Study
Recruiting
Do you use cannabis? Healthy male and female cannabis smokers (age 21-55) needed to evaluate the effects of cannabis for a UCLA Research Study. The study requires 1-3 screening visits (2 hours each) and 3 visits (9AM-3PM) over 1-4 weeks at the UCLA Medical Center. Compensation for time provided ($25-$399).
Conditions:
Healthy
Healthy Volunteers
Healthy Subjects
Cannabis Use
Featured Trial
Help Test New Technology
Recruiting
Are you in or near Hoboken, NJ? Over 55 years old and willing to look at some cool animations to help test a new artificial intelligence brain technology? Dandelion Science is a neuroscience startup funded by the National Institute of Health exploring new ways to deliver care. You will be compensated for your time in this study. Participation requires a recent eye exam within the past 2 years, or willing to have an exam in our office.
Conditions:
Healthy
Featured Trial
Chronic Obstructive Pulmonary Disease Study
Recruiting
This is a clinical research study to test the safety and effectiveness of an investigational medication as an add-on treatment for Chronic Obstructive Pulmonary Disease (COPD). Participants who qualify for the study will receive trial-related procedures and study medication at no cost and may be compensated up to $85 per visit for time and travel.
Conditions:
Chronic Obstructive Pulmonary Disease (COPD)
COPD
COPD Exacerbation
Copd Exacerbation Acute
Emphysema or COPD
* Compensation for time may be available
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Recruiting
This phase III trial compares early treatment with venetoclax and obinutuzumab versus delayed treatment with venetoclax and obinutuzumab in patients with newly diagnosed high-risk chronic lymphocytic leukemia or small lymphocytic lymphoma. Venetoclax is in a class of medications called B-cell lymphoma-2 (BCL-2) inhibitors. It may stop the growth of cancer cells by blocking Bcl-2, a protein needed for cancer cell survival. Immunotherapy with monoclonal antibodies, such as obinutuzumab, may help t... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
03/09/2024
Locations: UT Southwestern Clinical Center at Richardson/Plano, Richardson, Texas
Conditions: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
1 - 1 of 1